Cargando…
Elevation of 1-Hour Plasma Glucose During Oral Glucose Tolerance Testing Is Associated With Worse Pulmonary Function in Cystic Fibrosis
OBJECTIVE: Cystic fibrosis (CF)-related diabetes (CFRD) is associated with declining pulmonary function and increased mortality. During oral glucose tolerance testing (OGTT), CFRD is defined by 2-h plasma glucose (PG2). We hypothesized PG elevations during OGTT resolving by 2 h, not meeting CFRD cri...
Autores principales: | Brodsky, Jill, Dougherty, Shayne, Makani, Ramkrishna, Rubenstein, Ronald C., Kelly, Andrea |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024336/ https://www.ncbi.nlm.nih.gov/pubmed/21228248 http://dx.doi.org/10.2337/dc10-1604 |
Ejemplares similares
-
MON-184 Hypoglycemia During Mixed Meal Tolerance Testing and Early Glucose Dysregulation in Cystic Fibrosis
por: Kilberg, Marissa, et al.
Publicado: (2019) -
Impaired glucose tolerance and indeterminate glycemia in cystic fibrosis
por: Kasim, Nader, et al.
Publicado: (2021) -
Can continuous glucose monitoring predict cystic fibrosis-related diabetes and worse clinical outcome?
por: Zorron, Mariana, et al.
Publicado: (2022) -
Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance
por: Sheikh, Saba, et al.
Publicado: (2017) -
Glucose Tolerance during Pulmonary Exacerbations in Children with Cystic Fibrosis
por: Widger, John, et al.
Publicado: (2012)